Please login to the form below

Not currently logged in
Email:
Password:

biopharma

This page shows the latest biopharma news and features for those working in and with pharma, biotech and healthcare.

AZ’s Sean Bohen to exit after business overhaul; report

AZ’s Sean Bohen to exit after business overhaul; report

Immunocore, and Ludovic Helfgott – AZ’s head of cardiovascular and metabolic diseases – is set to join Novo Nordisk as executive vice president of its biopharma unit.

Latest news

  • Pfizer takeover rumour ignites Amarin shares Pfizer takeover rumour ignites Amarin shares

    Fish oil product shows great promise. Pfizer is rumoured to be on the brink of a deal to acquire small biopharma Amarin in the wake of stellar data for its purified

  • BMS and Celgene announce $74bn merger BMS and Celgene announce $74bn merger

    The biopharma mega-merger is back: Bristol-Myers Squibb is to pay $74bn to acquire Celgene in a deal which will shake up the sector and create a new leader in ... BMS CEO Giovanni Caforio. “Together with Celgene, we are creating an innovative biopharma

  • Pharma’s R&D productivity sinks to a new low Pharma’s R&D productivity sinks to a new low

    In addition to the 12 original cohort companies, since 2015 four smaller and more specialised biopharma companies have been used as an extension cohort of the R&D study, although Deloitte

  • Axovant drops last ‘legacy’ drug to focus on gene therapies Axovant drops last ‘legacy’ drug to focus on gene therapies

    That was followed swiftly by a $10m upfront deal with Benitec Biopharma for rights to a preclinical stage gene therapy for rare disease oculopharyngeal muscular dystrophy (OPMD), due to start trials

  • eConsent: Busting regulatory myths eConsent: Busting regulatory myths

    One of these is TransCelerate Biopharma’s eConsent initiative, which seeks to facilitate broad adoption of this technology and has provided a framework for eConsent digital components, as well as a

More from news
Approximately 9 fully matching, plus 359 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    Strongbridge. Biopharma/ Novo. Nordisk. MACRILEN (macimorelin) for diagnosis of adult growth.

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Onpattro’s competition. As is so typical of today’s biopharma sector, even when companies bring highly innovative medicines to market, there is very often a competitor or.

  • Redefining communications excellence Redefining communications excellence

    While biopharma companies can rely on third parties for lots of the communication creation process, their own staff typically play a central role in discussions about who the key stakeholders are

  • Chinese biotech’s global ambitions Chinese biotech’s global ambitions

    BeiGene aims to be the first home-grown big biopharma. " />. BeiGene aims to be the first home-grown big biopharma. " />. BeiGene aims to be the first home-grown big biopharma. BeiGene ... is one of a new wave of Chinese biopharma companies to list on

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    The rise of Chinese biopharma. One home-grown pharma company which could replicate this accomplishment is Beijing-headquartered BeiGene. ... BeiGene’s CEO John Oyler told a Goldman Sachs recent conference that a Chinese biopharma sector was ready to

More from intelligence
Approximately 1 fully matching, plus 66 partially matching documents found.

Latest appointments

More from appointments
Approximately 8 fully matching, plus 136 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics